Short interest for Acacia Research gives investors a sense of the degree to which investors are betting on the decline of Acacia Research's stock. Short interest data is updated every two weeks.

Acacia Research Stock (NASDAQ:ACTG), Short Interest Report

Acacia Research

Acacia Research Corp focuses on acquiring and managing companies across various industries, including industrial, energy, technology, and healthcare. It seeks to unlock value in businesses through strategic acquisitions, restructurings, and investments. The company operates three segments: Intellectual Property Operations, Industrial Operations, and Energy Operations. The Intellectual Property segment licenses and enforces patented technologies, while the Industrial segment designs and manufactures printers and consumable products for industrial printing applications. The Energy segment engages in oil and gas exploration, development, and production. The company generates the majority of its revenue from intellectual property operations, primarily in the United States.

Long Ideas

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

ACTG

CPBI

HWBK

PEBK

RILY

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.

Top 5 Financial Stocks Which You&#39;ll Regret Missing This Quarter

Movers

Media

General

Why Kohl&#39;s Shares Are Plunging Today

Earnings

Guidance

Buybacks

Acacia Research Stock Gains On Record Q4 Results, New Buyback

Acacia Research Corporation - Common Stock

Acacia Research Corp

Craig-Hallum analyst Anthony Stoss maintains Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) with a Buy and raises the price target from $6 to $7.

Price Target

Analyst Ratings

Craig-Hallum Maintains Buy on Acacia Research, Raises Price Target to $7

WIIM

Acacia Research shares are trading higher after the company reported better-than-expected Q4 EPS results and a year-over-year increase in Q4 revenue results.

Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:06 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Acacia Research beat estimated earnings by 971.0000000000001%, reporting an EPS of $0.75 versus an estimate of $0.07.
Revenue was up $79.19 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.15 which was followed by a 2.0% increase in the share price the next day.
Here's a look at Acacia Research's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.12</td>
<td>0.01</td>
<td>-0.02</td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.03</td>
<td>-0.32</td>
<td>-0.07</td>
<td>-0.5</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>8.00M</td>
<td>16.00M</td>
<td>16.00M</td>
<td>13.50M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>10.10M</td>
<td>7.90M</td>
<td>14.80M</td>
<td>13.12M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Acacia Research <a href="https://www.benzinga.com/quote/ACTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Acacia Research: Q4 Earnings Insights

Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.07 by 971.43 percent. This is a 250 percent increase over losses of $(0.50) per share from the same period last year. The company reported $92.31 million in sales this quarter. This is a 603.54 percent increase over sales of $13.12 million the same period last year.

Earnings Beats

Acacia Research Q4 EPS $0.75 Beats $0.07 Estimate, Sales $92.31M Up From $13.12M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) is projected to report earnings for its fourth quarter.
&bull; ImmunoPrecise Antibodies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) is likely to report quarterly loss at $0.07 per share on revenue of $4.50 million.
&bull; G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) is projected to report quarterly earnings at $0.67 per share on revenue of $817.48 million.
&bull; Dick&#39;s Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is estimated to report quarterly earnings at $3.35 per share on revenue of $3.80 billion.
&bull; Protalix BioTherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PLX#AMEX">PLX</a>) is likely to report quarterly loss at $0.03 per share on revenue of $5.80 million.
&bull; Hello Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOMO#NASDAQ">MOMO</a>) is likely to report quarterly earnings at $0.34 per share on revenue of $405.61 million.
&bull; Weibo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WB#NASDAQ">WB</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $455.09 million.
&bull; Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) is projected to report quarterly earnings at $0.96 per share on revenue of $331.79 million.
&bull; Akebia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) is expected to report quarterly loss at $0.04 per share on revenue of $55.39 million.
&bull; Kandi Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNDI#NASDAQ">KNDI</a>) is projected to report earnings for its fourth quarter.
&bull; Benson Hill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NYSE">BHIL</a>) is estimated to report quarterly loss at $0.17 per share on revenue of $87.30 million.
&bull; KE Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $2.63 billion.
&bull; Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) is expected to report quarterly earnings at $1.75 per share on revenue of $9.78 billion.
&bull; Hudson Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSON#NASDAQ">HSON</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $38.02 million.
&bull; InfuSystems Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INFU#AMEX">INFU</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $30.00 million.
&bull; HF Foods Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFFG#NASDAQ">HFFG</a>) is likely to report earnings for its fourth quarter.
&bull; Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) is estimated to report earnings for its Fiscal Year 2023.
&bull; Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $23.60 million.
&bull; Xunlei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNET#NASDAQ">XNET</a>) is likely to report earnings for its fourth quarter.
&bull; Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) is projected to report quarterly earnings at $1.32 per share on revenue of $150.45 million.
&bull; Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is projected to report quarterly loss at $0.05 per share on revenue of $6.85 million.
&bull; Century Casinos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTY#NASDAQ">CNTY</a>) is expected to report quarterly loss at $0.36 per share on revenue of $142.31 million.
&bull; Katapult Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPLT#NASDAQ">KPLT</a>) is expected to report quarterly loss at $1.79 per share on revenue of $55.81 million.
&bull; UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) is estimated to report quarterly loss at $0.68 per share on revenue of $22.57 million.
&bull; Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) is projected to report quarterly loss at $0.05 per share on revenue of $47.05 million.
&bull; RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $339.48 million.
&bull; Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $7.00 million.
&bull; Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) is estimated to report quarterly loss at $0.25 per share on revenue of $360 thousand.
&bull; United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) is projected to report earnings for its first quarter.
&bull; BK Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) is likely to report earnings for its fourth quarter.
&bull; Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $166.15 million.
&bull; Mondee Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOND#NASDAQ">MOND</a>) is likely to report quarterly loss at $0.12 per share on revenue of $55.00 million.
&bull; GoHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOCO#NASDAQ">GOCO</a>) is likely to report quarterly earnings at $2.72 per share on revenue of $363.88 million.
&bull; SecureWorks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWX#NASDAQ">SCWX</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $87.18 million.
&bull; Aveanna Healthcare Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAH#NASDAQ">AVAH</a>) is projected to report quarterly loss at $0.02 per share on revenue of $467.40 million.
&bull; PSQ Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) is expected to report quarterly loss at $0.47 per share on revenue of $2.47 million.
&bull; Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $1.69 billion.
&bull; CION Invt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CION#NYSE">CION</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $58.33 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) is expected to report quarterly loss at $0.09 per share on revenue of $36.93 million.
&bull; Montauk Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) is estimated to report quarterly earnings at $0.07 per share on revenue of $56.87 million.
&bull; Getty Images Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $216.46 million.
&bull; Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) is likely to report quarterly earnings at $7.53 per share on revenue of $3.53 billion.
&bull; Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) is projected to report quarterly loss at $1.41 per share on revenue of $38.09 million.
&bull; Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) is expected to report quarterly loss at $0.13 per share on revenue of $3.22 million.
&bull; Smartsheet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) is estimated to report quarterly earnings at $0.18 per share on revenue of $255.38 million.
&bull; Phreesia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHR#NYSE">PHR</a>) is expected to report quarterly loss at $0.26 per share on revenue of $93.53 million.
&bull; Despegar.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) is projected to report quarterly earnings at $0.17 per share on revenue of $191.43 million.
&bull; Frequency Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) is projected to report earnings for its third quarter.
&bull; Pyxis Tankers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXS#NASDAQ">PXS</a>) is projected to report earnings for its fourth quarter.
&bull; American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $172.90 million.
&bull; The One Group Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $98.04 million.
&bull; Urgently (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULY#NASDAQ">ULY</a>) is likely to report earnings for its fourth quarter.
&bull; Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) is likely to report quarterly loss at $0.14 per share on revenue of $1.25 million.
&bull; Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) is likely to report quarterly loss at $0.50 per share on revenue of $1.63 million.
&bull; Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $12.75 million.
&bull; Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) is projected to report quarterly loss at $0.02 per share on revenue of $9.03 million.
&bull; Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) is projected to report earnings for its fourth quarter.
&bull; Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) is projected to report quarterly earnings at $0.26 per share on revenue of $275.87 million.
&bull; Tilly&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) is projected to report quarterly loss at $0.22 per share on revenue of $171.65 million.
&bull; CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) is projected to report quarterly loss at $0.14 per share on revenue of $9.28 million.
&bull; Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $125.84 million.
&bull; Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) is projected to report quarterly loss at $0.45 per share on revenue of $20 thousand.
&bull; Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) is expected to report earnings for its fourth quarter.
&bull; Redwire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) is expected to report quarterly loss at $0.12 per share on revenue of $59.72 million.
&bull; Fathom Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTHM#NASDAQ">FTHM</a>) is estimated to report quarterly loss at $0.32 per share on revenue of $80.97 million.
&bull; Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $124.61 million.
&bull; Karat Packaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRT#NASDAQ">KRT</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $95.48 million.
&bull; Mobile Infrastructure (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) is estimated to report earnings for its fourth quarter.
&bull; Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) is likely to report quarterly loss at $0.03 per share on revenue of $256.27 million.
&bull; Cardlytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) is projected to report quarterly earnings at $0.12 per share on revenue of $89.55 million.
&bull; Eton Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETON#NASDAQ">ETON</a>) is expected to report quarterly loss at $0.04 per share on revenue of $7.70 million.
&bull; EverCommerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVCM#NASDAQ">EVCM</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $172.41 million.
&bull; Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) is expected to report quarterly loss at $0.20 per share on revenue of $3.62 million.
&bull; Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $8.00 million.
&bull; Alta Equipment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTG#NYSE">ALTG</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $483.69 million.
&bull; Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $291.55 million.
&bull; Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is likely to report earnings for its fourth quarter.
&bull; aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFE#NASDAQ">LIFE</a>) is estimated to report quarterly loss at $0.24 per share on revenue of $50 thousand.
&bull; Clipper Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLPR#NYSE">CLPR</a>) is projected to report earnings for its fourth quarter.
&bull; Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) is likely to report quarterly earnings at $4.38 per share on revenue of $5.14 billion.
&bull; Heritage Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGBL#NASDAQ">HGBL</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $15.35 million.
&bull; NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) is projected to report quarterly loss at $0.14 per share on revenue of $8.94 million.
&bull; Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>) is expected to report quarterly loss at $0.01 per share on revenue of $43.93 million.
&bull; Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) is likely to report earnings for its Fiscal Year 2023.
&bull; FutureFuel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) is likely to report earnings for its fourth quarter.
&bull; Harte-Hanks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HHS#NASDAQ">HHS</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $47.00 million.
&bull; Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) is likely to report quarterly loss at $0.31 per share on revenue of $35.64 million.
&bull; PagerDuty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $110.40 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ADBE

AGEN

AGRO

AKBA

ALAR

ALLO

ALTG

AMPS

AUTL

AVAH

Mobile Infrastructure Corporation Common Stock

BEEP

BEKE

BHIL

BKTI

BLND

BLNK

BRLT

CDLX

CION

CLPR

CNTY

CODX

CSIQ

CTSO

DESP

ETON

EVCM

EVOK

FEIM

FTHM

FUTU

GETY

GIII

GOCO

GURU

HFFG

HGBL

HSON

INFU

KNDI

KODK

KOPN

KPLT

LIFE

MCHX

MNTK

MOLN

MOMO

MOND

PHAR

PSQH

RGTI

RMBL

SCWX

SKLZ

SMAR

Spruce Power Holding Corporation Class A Common Stock

SPRU

STKS

TLYS

ULTA

URGN

VXRT

XNET

ZUMZ

Earnings Scheduled For March 14, 2024

Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) is set to give its latest quarterly earnings report on Thursday, 2024-03-14. Here's what investors need to know before the announcement.
Analysts estimate that Acacia Research will report an earnings per share (EPS) of $0.07. 
Acacia Research bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.15, which was followed by a 1.65% increase in the share price the next day.
Here's a look at Acacia Research's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.12</td>
<td>0.01</td>
<td>-0.02</td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.03</td>
<td>-0.32</td>
<td>-0.07</td>
<td>-0.5</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>-5.0%</td>
<td>-1.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of Acacia Research were trading at $4.02 as of March 12. Over the last 52-week period, shares are down 8.82%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ACTG/earnings">To track all earnings releases for Acacia Research visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Acacia Research

Acquisition Anticipated to Add Over 470 Operated Producing Wells Across Approximately 140,000 Net Acres with Expected Annualized Asset-Level Cash Flows of Approximately $45 Million
Acacia Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) ("Acacia") today announced that its majority owned subsidiary, Benchmark Energy II, LLC (together with its subsidiaries, "Benchmark"), has entered into a Purchase and Sale Agreement ("PSA") to acquire certain upstream assets and related facilities (the "Assets") in Texas and Oklahoma from a private seller (such transaction, the "Acquisition"). The Acquisition is anticipated to expand the Benchmark portfolio, adding approximately 140,000 net acres and approximately 470 operated producing wells in the prolific Western Anadarko Basin throughout the Texas Panhandle and Western Oklahoma.
Acquisition Highlights
<ul>
<li>Expanded operated position throughout the core of the Western Anadarko Basin with over 110,000 net acres, 100% of which is held-by-production, with an additional 27,000 net acres in the emerging Cherokee play</li>
<li>Liquids-rich, low-decline, mature production base of approximately 6,000 barrels of oil equivalent per day across approximately 470 operated wells</li>
<li>Significant opportunity set of field enhancement opportunities including artificial lift optimization, workovers and return-to-production projects</li>
<li>Material exposure to the emerging Cherokee development play via operated acreage and non-operated arrangements with best-in-class operators</li>
<li>Benchmark anticipates hedging a significant amount of production</li>
</ul>
The Acquisition expands upon Acacia's strategy within its Benchmark subsidiary of driving returns through a focus on cash flow. This is accomplished through acquiring predictable and shallow decline, cash-flowing oil and gas properties whose value can be enhanced via a disciplined, field optimization strategy, with risk managed through robust commodity hedges and low leverage.
Kirk Goehring, Benchmark's Chief Executive Officer, commented: "The acquisition of these assets represents a transformative moment in Benchmark Energy's history and an important next step in our partnership with Acacia and McArron. This unique asset is expected to deliver attractive, mature production with multiple drivers to enhance value. After closing this acquisition, Benchmark will have a large, contiguous acreage position in the heart of the Mid-Continent, and incremental scale to continue driving meaningful operational enhancements to create attractive returns for our stakeholders for many years to come."
MJ McNulty, Jr., Acacia's Chief Executive Officer, added, "We have always envisioned the Benchmark subsidiary as a platform, partnering with its highly talented leadership team, to acquire high-quality, cashflow-generating oil and gas assets. The Benchmark team has an established track record for acquiring excellent assets that possess attractive return profiles. This transaction is an example of that strategy in action and a meaningful first step of what we expect to be multiple acquisitions within the Benchmark platform. We continue to believe there is an opportunity to acquire outstanding assets at attractive valuations."
Jonny Jones, McArron's Chief Executive Officer, added, "This transaction further expands the exciting partnership between Acacia and McArron in our support of Benchmark. Kirk and his team have a deep familiarity with these high-quality assets, and they will bring Benchmark the required scale to drive meaningful value within the combined enterprise."
Enhancing Scale in the Anadarko Basin
The Acquisition includes an interest in approximately 470 operated wells producing approximately 6,000 net mboe/d in the core of the Western Anadarko Basin, as well as a non-operated interest in the undeveloped Cherokee play. The wells are mature, low-decline production and will add significant diversification to Benchmark's production, with a balanced pro-forma portfolio of approximately 60% liquids and 40% natural gas. Further, the Assets' proximity to Benchmark's existing operations in Texas creates further potential to develop operational synergies of scale in the basin.
Additional Information
The transaction is expected to be funded utilizing cash from Benchmark's existing owners, Acacia and McArron Partners, as well as committed debt financing from a group of local, regional banks. Acacia's share of the consideration is expected to be approximately $57.5 million. Closing of the transaction, which is expected in the second quarter of 2024, is subject to customary closing conditions and termination rights.
Additional details about the acquisition are included in a Form 8-K filed by Acacia today with the Securities and Exchange Commission.

Acacia Research Expands Oil And Gas Investments Through Benchmark Energy's Transformative Acquisition In The Western Anadarko Basin; Anticipated to Add Over 470 Operated Producing Wells Across ~140,000 Net Acres with Expected Annualized Asset-Level Cash Flows of ~$45M

Acacia Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) today announced that Martin ("MJ") D. McNulty, Jr. has been named as Acacia's permanent Chief Executive Officer. Mr. McNulty has been serving as the Company's Interim Chief Executive Officer since November 1, 2022.
In addition, the Board of Directors expanded the size of the Board from six to seven directors, and the Board appointed Mr. McNulty as a director of the Company to serve until the Company's 2024 annual meeting of stockholders.
"The Board is extremely grateful for MJ's contributions as Interim Chief Executive Officer and believes he is the right leader for the company going forward," commented Gavin Molinelli, Acacia's Chairman. "Since being appointed to his interim role, MJ has worked closely with the Board while spearheading Acacia's efforts to build a top-notch team and execute on the company's acquisition strategy. The Board is confident that MJ possesses the unique skillset, leadership and strategic vision to lead Acacia forward. We look forward to continuing to work with MJ to create value at the Company."

Management

Acacia Research Appoints Martin D. McNulty, Jr. To Board of Directors, Named Permanent CEO

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>)</h3>
<ul>
<li>On Nov. 8, B. Riley Financial posted a loss for the third quarter. Bryant Riley, Chairman and Co-Chief Executive Officer of B. Riley Financial said, &quot;During the third quarter, we generated meaningful operating adjusted EBITDA consistent with our platform objectives to drive better results from a broader client set. Despite lower investment marks that reflect a difficult small cap market environment, we are as encouraged by the middle market setup as we have been in years and expect to take advantage of recent market dislocations.&quot; The company&rsquo;s stock fell around 19% over the past five days and has a <a href="https://www.benzinga.com/quote/RILY">52-week low of $16.65 </a>.</li>
<li>RSI Value: 28.07</li>
<li>RILY Price Action: Shares of B. Riley Financial gained 1.8% to close at $18.23 on Wednesday.</li>
</ul>
<h3>Acacia Research Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/actg#NASDAQ">ACTG</a>)</h3>
<ul>
<li>On Nov. 13, Acacia Research posted a loss for the third quarter. Martin D. McNulty, Jr. &quot;MJ&quot;, Interim Chief Executive Officer, stated, &quot;In the last few weeks, our value-creation strategy has accelerated. We established a platform, in collaboration with accomplished executives we have worked with in the past, to acquire producing, cash generating oil and gas assets at what we believe will be favorable valuations.&quot; The company&rsquo;s stock fell around 13% over the past six months. It <a href="https://www.benzinga.com/quote/ACTG"> has a 52-week low </a> of $3.43.</li>
<li>RSI Value: 21.85</li>
<li>ACTG Price Action: Shares of Acacia Research fell 0.6% to close at $3.62 on Wednesday.</li>
</ul>
<h3>Central Plains Bancshares, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpbi#NASDAQ">CPBI</a>)</h3>
<ul>
<li>Central Plains Bancshares has a market capitalization of $41.019 million. The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/quote/CPBI"> low of $8.20.</a></li>
<li>RSI Value: 22.25</li>
<li>CPBI Price Action: Shares of Central Plains Bancshares fell 0.5% to close at $9.93 on Wednesday.</li>
</ul>
<h3>Peoples Bancorp of North Carolina, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pebk#NASDAQ">PEBK</a>)</h3>
<ul>
<li>On Oct. 23, Peoples Bancorp of NC reported a decline in EPS for the third quarter. The company&rsquo;s shares lost around 17% year-to-date. The company&rsquo;s 52-week low is $16.35.</li>
<li>RSI Value: 28.70</li>
<li>PEBK Price Action: Shares of Peoples Bancorp of North Carolina fell 0.2% to close at $27.00 on Wednesday.</li>
</ul>
<h3>Hawthorn Bancshares, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwbk#NASDAQ">HWBK</a>)</h3>
<ul>
<li>On Oct. 25, Hawthorn Bancshares reported a decline in EPS for the third quarter. The company&rsquo;s shares fell around 2% year-to-date. The company <a href="https://www.benzinga.com/quote/HWBK"> has a 52-week low </a> of $15.02.</li>
<li>RSI Value: 26.58</li>
<li>HWBK Price Action: Shares of Hawthorn Bancshares rose 0.1% to close at $21.28 on Wednesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/11/36016427/kroger-dell-and-3-stocks-to-watch-heading-into-thursday"> Kroger, Dell And 3 Stocks To Watch Heading Into Thursday</a>

Top 5 Financial Stocks Which You'll Regret Missing This Quarter

Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) reported its Q3 earnings results on Monday, November 13, 2023 at 04:06 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Acacia Research missed estimated earnings by 125.0%, reporting an EPS of $-0.03 versus an estimate of $0.12.
Revenue was down $5.78 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.33 which was followed by a 5.1% drop in the share price the next day.
Here's a look at Acacia Research's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.01</td>
<td>-0.02</td>
<td></td>
<td>-0.04</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.32</td>
<td>-0.07</td>
<td>-0.5</td>
<td>0.02</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>16.00M</td>
<td>16.00M</td>
<td>13.50M</td>
<td>13.50M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>7.90M</td>
<td>14.80M</td>
<td>13.12M</td>
<td>15.88M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Acacia Research <a href="https://www.benzinga.com/quote/ACTG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Acacia Research Q3 Earnings

Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.12 by 125 percent. This is a 250 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $10.10 million which beat the analyst consensus estimate of $8.00 million by 26.25 percent. This is a 36.39 percent decrease over sales of $15.88 million the same period last year.

Acacia Research Q3 EPS $(0.03) Misses $0.12 Estimate, Sales $10.10M Beat $8.00M Estimate

Acacia Research Acquires Majority Stake In Benchmark Energy; Terms Not Disclosed

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acacia Research Stock (NASDAQ:ACTG), Short Interest Report

People Also Watch